RecBio

About:

Focusing on major innovative vaccines with independent intellectual property rights.

Website: https://www.recbio.cn/

Top Investors: Temasek Holdings, HongShan, Vertex Ventures China, Legend Capital, BioVenture

Description:

Recbio, founded in 2012, is an innovative vaccine company based on independent research and development technology. It is dedicated to establishing a full value chain for innovative vaccines, including research and development, manufacturing, and commercialization. The company has always adhered to its mission of "creating first-class vaccines and protecting human health". With a strong R&D engine comprised of novel adjuvants, protein engineering, immunological evaluation, and other core technology platforms, the company is strategically focusing on disease areas with high burdens such as cervical cancers.